OTC · GABLF
GABY Inc.
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
Loading market information…
OTC · IWINF · USD
Stock price, earnings
Quote as of Aug 9, 2024, 01:33 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Irwin Naturals Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Irwin Naturals Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Los Angeles, California, Irwin Naturals Inc. operates as a herbal supplement provider, primarily focusing on the distribution of CBD products. Its merchandise is available to consumers worldwide, accessible through its online platforms and an extensive network of approximately 100,000 retail stores. The company previously traded under the name Datinvest International Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Dec 31, 2021 |
| $0.01 |
| $100.34M |
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
$0.00-$0.00 (-85.71%)
RCMW Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Kallo Inc.: Healthcare · Medical - Healthcare Information Services.
$0.01+$0.01 (+166.67%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.08-$0.09 (-51.52%)
Parnell Pharmaceuticals Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 77.14% below the high.
$0.00-$0.00 (-15.56%)
AusCann Group Holdings Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.02+$0.00 (+16.18%)
Can B Corp.’s quoted price sits in the lower half of its reported 52-week range, 89.55% below the high.
